Services

Type of Care

  • Substance use treatment
  • Treatment for co-occurring serious mental health illness/serious emotional disturbance and substance use disorders

Service Settings

  • Outpatient
  • Outpatient methadone/buprenorphine or naltrexone treatment
  • Regular outpatient treatment
  • Telemedicine/telehealth

Opioid Medications used in Treatment

  • Buprenorphine used in Treatment
  • Naltrexone used in Treatment

Type of Alcohol Use Disorder Treatment

  • Does not treat alcohol use disorder

Type of Opioid Treatment

  • Buprenorphine maintenance
  • Buprenorphine maintenance for predetermined time
  • Prescribes buprenorphine
  • Administers naltrexone
  • Relapse prevention from naltrexone

Pharmacotherapies

  • Acamprosate (Campral®)
  • Buprenorphine sub-dermal implant (Probuphine®)
  • Buprenorphine with naloxone (Ex. Suboxone®)
  • Buprenorphine without naloxone
  • Buprenorphine (extended-release, injectable, for example, Sublocade®)
  • Naltrexone (oral)
  • Naltrexone (extended-release, injectable naltrexone (Vivitrol®))
  • Medications for psychiatric disorders
  • Lofexidine
  • Clonidine

Treatment Approaches

  • Relapse prevention
  • Substance use counseling approach

Facility Operation (e.g., Private, Public)

  • Private for-profit organization

Payment/Insurance/Funding Accepted

  • Medicaid
  • Private health insurance
  • Cash or self-payment

Assessment/Pre-treatment

  • Comprehensive mental health assessment
  • Comprehensive substance use assessment
  • Interim services for clients

Screening & Testing

  • Drug or alcohol urine screening
  • Screening for mental disorders
  • Screening for substance use

Transitional Services

  • Aftercare/continuing care
  • Naloxone and overdose education
  • Outcome follow-up after discharge

Ancillary Services

  • Mental health services

Tobacco/Screening Services

  • Screening for tobacco use

Facility Smoking Policy

  • Smoking not permitted

Gender Accepted

  • Female
  • Male